In addition, pharmacological inhibition of CCL2/CCR4/Vav2/Rac1/MLC signaling pathway can effectively reduce the motility of cancer cells, thereby inhibiting local invasion and distant lymph node metastasis in head and neck squamous cell carcinoma (HNSCC) cells (33). Here, MLC1 is linked to head and neck squamous cell carcinoma.